Improving the diagnosis of myelodysplastic syndrome by red blood cell parameters.

Zhu, Ying; Han, Suyang; Chen, Xue; Wu, Sanyun; Xiong, Bei

Zhu, Ying; Han, Suyang; Chen, Xue; Wu, Sanyun; Xiong, Bei.

Afiliación

Zhu Y; The Second Clinical School of Wuhan University, Zhongnan Hospital of Wuhan University, Wuhan, China.
Han S; The Second Clinical School of Wuhan University, Zhongnan Hospital of Wuhan University, Wuhan, China.
Chen X; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wu S; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xiong B; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China. xiongbei909@aliyun.com.

Clin Transl Oncol ; 25(10): 2983-2990, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37081223

Asunto(s)

Eritrocitos; Síndromes Mielodisplásicos; Humanos; Estudios Retrospectivos; Índices de Eritrocitos; Síndromes Mielodisplásicos/diagnóstico; Pronóstico

Palabras clave

Diagnosis; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Myelodysplastic syndrome; Red cell distribution width

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Eritrocitos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Transl Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google